We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current JAGX market cap is 11.69M. The company's latest EPS is USD -3.5005 and P/E is -0.29.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.81M | 2.3M | 2.35M | 2.72M | 3.11M |
| Operating Income | -8.79M | -7.56M | -8.22M | -7.2M | -7.26M |
| Net Income | -7.78M | -9.17M | -9.23M | -9.49M | -9.85M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 5.78M | 9.39M | 4.34M | 11.96M | 9.76M |
| Operating Income | -28.95M | -26.61M | -40.71M | -34.42M | -34.29M |
| Net Income | -44.73M | -38.61M | -52.6M | -47.45M | -41.3M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 45.38M | 50.76M | 55.39M | 61.46M | 58.47M |
| Total Liabilities | 43.96M | 45.87M | 41.09M | 42.4M | 42.88M |
| Total Equity | 1.42M | 4.9M | 11.82M | 16.58M | 13.1M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 36.41M | 42.84M | 53.27M | 47.45M | 50.76M |
| Total Liabilities | 15.84M | 25.64M | 41.41M | 48.81M | 45.87M |
| Total Equity | 10.67M | 17.2M | 11.85M | -1.36M | 4.9M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -25.79M | -33.24M | -7.05M | -15.22M | -21.56M |
| Investing | N/A | N/A | N/A | -16k | -16k |
| Financing | 23.58M | 34.23M | 12.27M | 24.84M | 28.37M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -20.46M | -15.28M | -34.97M | -33.1M | -33.24M |
| Investing | N/A | -7k | -6k | -1.68M | N/A |
| Financing | 21.77M | 19.49M | 43.94M | 23.18M | 34.23M |
| Market Cap | 11.69M |
| Price to Earnings Ratio | -0.29 |
| Price to Sales Ratio | 1.22 |
| Price to Cash Ratio | 1.84 |
| Price to Book Ratio | 2.43 |
| Dividend Yield | - |
| Shares Outstanding | 11.8M |
| Average Volume (1 week) | 423.91k |
| Average Volume (1 Month) | 606.55k |
| 52 Week Change | -89.15% |
| 52 Week High | 21.60 |
| 52 Week Low | 0.8435 |
| Spread (Intraday) | 0.01 (0.5%) |
| Company Name | Jaguar Health Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://jaguar.health |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
